[Event Report] NCDs-related Cross-project Meeting: the 1st NCDs Meeting in Kyushu (December 7, 2023)
date : 1/30/2024
Tags: Cardiovascular Diseases, Kidney Disease, NCDs, Obesity
![[Event Report] NCDs-related Cross-project Meeting: the 1st NCDs Meeting in Kyushu (December 7, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/ncd-ckd-ob-cvd-20231207-PC071570.jpg)
The “1st NCDs Meeting in Kyushu” was jointly held by the Kidney Disease Control Promotion Project, the Obesity Control Promotion Project, and the Cardiovascular Disease Control Promotion Project of Health and Global Policy Institute (HGPI). This meeting was held to deepen the understanding of chronic and non-communicable diseases (NCDs), which require intervention and management across the board in communities and workplaces. The meeting also discussed how NCDs measures should be tailored to local conditions and characteristics, as well as to promote the horizontal development of policies. The purpose of the event was to build a network among local governments in order to promote policy development.
After lectures were conducted by specialists in kidney disease, cardiovascular disease, and obesity, participants shared good practices and discussed issues and future prospects for each municipality.
The discussion points of the group discussion are as follows.
Issue 1: What are more effective methods and approaches to recommend health checkups to the target population, given the limitations of the current administrative recommendation for health checkups?
Issue 2: What should be the role of prefectures, municipalities, and public health centers, and how should cross-disease collaboration within each municipality be organized?
Issue 3: How can obesity, which is expected to be newly addressed, be integrated into regional measures against cardiovascular disease, kidney disease, and diabetes?
Group discussions and a reception held after the meeting provided a lively exchange of opinions and information among the participants.
[Event overview]
- Date & time: Thursday, December 7, 2023; from 13:00 to 18:00 JST
- Format: In-person only
- Target: Persons in charge of measures for kidney disease, cardiovascular disease, diabetes and obesity in each prefecture and city in Shikoku and Kyushu
[Program]
Part I: Latest trend and topics on Non-communicable Diseases
13:00-13:10 Opening Remarks and Explanatory Introduction
Haruka Sakamoto (Senior Manager, Health and Global Policy Institute)
13:10-13:50 Lecture 1: “The latest trend and evidence on non-communicable diseases -Cardiovascular Diseases-”
Koji Maemura (Professor, Department of Cardiovascular Medicine, Graduate School of Biomedical Sciences, Nagasaki University)
13:50-14:30 Lecture 2: “Fighting the Obesity Pandemic: fostering empathy – building a society that moves beyond individual responsibility to support those struggles with obesity”
Ichiro Tatsuno (Chairman, Japanese Society for Treatment of Obesity / President, Chiba Prefectural University of Health Sciences)
14:30-15:10 Lecture 3: “Trends in Pathophysiology and Treatment of Renal Diseases – Including Regional Cooperation and Future Prospects”
Masashi Mukoyama (Professor, Department of Nephrology, Faculty of Life Sciences, Kumamoto University)
15:10-15:20 Break (10 minutes)
Part II: Group Discussion
15:20-16:55 Group Discussion by Administrative Officers
Theme: “Lessons Learned, Challenges and Future Prospects in NCDs Control in Local Governments”
Sharing best practices (in no particular order): Kumamoto prefecture and Nagasaki prefecture
Moderator:
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute)
Eri Yoshimura (Senior Manager, Health and Global Policy Institute)
16:55-17:00 Summary of Discussion and Closing remarks
Haruka Sakamoto (Senior Manager, Health and Global Policy Institute)
17:00-18:00 Receptions and Networking
日本語
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Policy Recommendations] Establishing an Integrated Care System for Pain from the Perspectives of People with Lived Experience (March 29, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] Participation in an International Survey on Brain Health for Young People “The Next Generation (NextGen) Brain Health Research Program” (July 1, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Japanese Version Release] “Call for Actionable Steps in Response to the Rising Threat of Antimicrobial Resistance (AMR)” (July 3, 2024)
Featured Posts
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)
-
2024-07-17
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Towards Overcoming Kidney Disease: Strengthening Measures Against CKD” (June 7, 2024)
-
2024-07-18
[Registration Open] (Hybrid Format) Kidney Disease Control Promotion Project Public Symposium “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” (August 28, 2024)
-
2024-07-22
[HGPI Policy Column] No. 44 — From the Planetary Health Policy Project, Part 9 “Connecting Climate Minds: the Intersection of Climate Change and Mental Health”
-
2024-07-23
[Registration Open] (Webinar) HGPI Special Seminar “The Emerging Threat of Antifungal Resistance — Considering Infectious Diseases Caused by Mold and Measures to Combat Drug Resistance” (August 23, 2024)